A theme focused on advancing joint research and commercialization of a regenerative medicine product for intestinal ganglion cell paucity by combining dental pulp stem cells with Mochida Pharmaceutical's expertise in the gastrointestinal field. Research and development with Kyushu University has also progressed following selection for an AMED project.